Ottimo Pharma
Company

Ottimo Pharma

Biotechnology Research Manager Jobs 20 employees
Employees
20
Contacts
4
Emails
4
Phones
2

Ottimo Pharma Overview

Headquarters
Manager Jobs
Industry
Biotechnology Research
Employees
20
Founded
2020
Funding
140.0M
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)

About Ottimo Pharma

Ottimo Pharma is a private biotechnology company, co-founded in 2020 by Medicxi and Jonny Finlay, focused on the development of pioneering innovative cancer therapies for solid tumors. The Company's lead program, Jankistomig, is a PD1-VEGFR2 bi-functional antibody designed to target both immune checkpoint inhibition and angiogenesis in a single IgG therapy. By advancing this dual-pathway approach, Ottimo Pharma aims to improve cancer treatment outcomes and reduce overall healthcare burden. The Company boasts a world-class leadership team, including David Epstein as Chair and CEO, Mehdi Shahidi as Head of Development and CMO, and James Sabry as Vice-Chair of the Board. Ottimo Pharma anticipates filing an IND in late 2025.

Ottimo Pharma Contact Details

People in AeroLeads
4
With contact data
4
Email contacts
4
100.0% coverage
Phone contacts
2
50.0% coverage

Ottimo Pharma Org Chart

Sample employees and titles
Name Title Contact
Gabriela Rossi Regulatory Affairs Professional
Email
Susan Singer Director of Executive Administration and Operations
Email Phone
Julio Gagne Oncology and Rare Disease Drug Development Executive
Email Phone
Spencer Fisk Chief Technical and Quality Officer @ Ottimo Pharma
Email

Employees by Management Level

Individual contributor 2 profiles
Executive 1 profile
Director 1 profile

Compare Similar Companies to Ottimo Pharma